SCHEMBL11933621

SCHEMBL11933621

C[n+]1cc(-c2cccc3ccccc23)cc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 5/20 0.44
▸ CA1 P00915 5/20 0.44
▸ CA2 P00918 5/20 0.44
▸ CA9 Q16790 5/20 0.44
▸ TERT O14746 2/20 0.43
▸ MCL1 Q07820 2/20 0.41
▸ ACMSD Q8TDX5 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALPL P05186 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ PPARG P37231 3/20 0.38
▸ PPARA Q07869 3/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PPARD Q03181 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ RCE1 Q9Y256 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11933622 0.76 CYP1A2 (0.41) TERTGAARAB9A
SCHEMBL12075034 0.74 TERT (0.43) CA1CA2CA9TERTKDM4E
SCHEMBL2010178 0.71 CA12 (0.50) CA12CA1CA2CA9MCL1
SCHEMBL29866205 0.71 CA12 (0.50) CA12CA1CA2CA9MCL1
SCHEMBL11933620 0.71 TERT (0.41) TERTGAARAB9A
SCHEMBL31742566 0.70 MCL1 (0.54) CA12CA1CA2CA9MCL1
SCHEMBL29628903 0.69 MCL1 (0.53) CA12CA1CA2CA9MCL1
SCHEMBL14036308 0.69 MCL1 (0.53) CA12CA1CA2CA9MCL1
SCHEMBL316112 0.69 TNF (0.57) CA12CA1CA2CA9MCL1
SCHEMBL3798335 0.69 CA12 (0.62) CA12CA1CA2CA9MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230264181-A1 RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK ACENET INC (JP) 2023-08-24 — — US disclosed
US-11673129-B2 Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock ACENET INC. (JP) 2023-06-13 — — US disclosed
EP-2479160-B1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND UNIV OSAKA (JP) 2015-09-09 — — EP disclosed
EP-2479160-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND Osaka University (JP) 2012-07-25 — — EP disclosed
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND OSAKA UNIVERSITY (JP) 2012-07-05 — — US disclosed
US-7977486-B2 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives OSAKA UNIVERSITY (JP) 2011-07-12 — — US disclosed
US-7977486-B2 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives OSAKA UNIVERSITY (JP) 2011-07-12 — — US disclosed
WO-2011034071-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND 国立大学法人大阪大学 (JP) 2011-03-24 — — WO disclosed
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES OSAKA UNIVERSITY (JP) 2010-01-07 — — US disclosed
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES OSAKA UNIVERSITY (JP) 2010-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230264181-A1 RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK LPO, CAT, NOX4 CA12 1298/4885CA1 446/4885CA2 97/4885
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND TYR, AOX1, POR CA12 4703/4885CA1 4776/4885CA2 4177/4885
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES APEX1, NQO1, POT1 CA12 4695/4885CA1 2522/4885CA2 1404/4885
US-11673129-B2 Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock LPO, CAT, NOX4 CA12 1298/4885CA1 446/4885CA2 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback